TYRP1 mRNA goes fishing for miRNAs in melanoma

Nature Cell Biology 19, 1311 (2017). doi:10.1038/ncb3637 Authors: Maria S. Soengas &Eva Hernando A variety of non-coding RNAs have been reported as endogenous sponges for cancer-modulating miRNAs. However, miRNA trapping by transcripts with protein-coding functions is less understood. The mRNA of TYRP1 is now found to sequester the tumour suppressor miR-16 on non-canonical miRNA response elements in melanoma, thereby promoting malignant growth.
Source: Nature Cell Biology - Category: Cytology Authors: Tags: News and Views Source Type: research

Related Links:

THURSDAY, July 19, 2018 -- Hand-holding and squeezing a stress ball do not provide anxiety reduction among patients during excisional removal of non-melanoma skin cancer, according to a study published online July 18 in JAMA Dermatology. Arianna F....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
CONCLUSIONS: As transplant recipients are susceptible to skin changes, especially after immunosuppressant treatments, a dermatological follow-up should be scheduled for each patient. PMID: 30014685 [PubMed - as supplied by publisher]
Source: Giornale Italiano di Dermatologia e Venereologia - Category: Dermatology Tags: G Ital Dermatol Venereol Source Type: research
This study evaluates the impact of CXCL5 expression on the tumor mircoenvironment in a syngeneic mouse melanoma model.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
In this study we investigate the significance of BAP1 in canine melanoma. Nuclear BAP1 protein was detected in five canine oral melanoma cell lines using an antibody commonly used for analysis of human tissues. BAP1 loss of function mutations often lead to loss of nuclear BAP1 (nBAP1) expression in humans; this is associated with a poorer prognosis in uveal and mucosal melanoma. Therefore, as a prelude to a study evaluating the prognostic significance of nBAP1 expression in dogs, immunohistochemistry (IHC) was used to assess cases of canine melanoma for nBAP1 expression. In 89 cases where tumour cells were identified by me...
Source: Journal of Comparative Pathology - Category: Pathology Source Type: research
TRIBBLES proteins are pseudokinases that bind and modulate the activity of several signalling molecules, including kinases, phosphatases, transcription factors and components of the ubiquitin proteasome system. From their first identification in mammalian cells, TRIBBLES have been recognised as inducible genes, modulated by a wide range of mitogens and stressors, and associated with downstream regulation of key signalling pathways, including those of AKT, ATF4, NF-kB and MAPKs [1-3]. TRIBBLES pseudokinases are involved in different disease pathways and in many cancer types, including solid tumours, such as melanoma, liver ...
Source: Experimental Hematology - Category: Hematology Authors: Source Type: research
WEDNESDAY, July 18, 2018 -- The first blood test to detect melanoma skin cancer in its early stages has been created, according to a study published in the July 17 issue of Oncotarget. Pauline Zaenke, of Edith Cowan University in Perth, Australia,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor. Cancer Biomark. 2018 Jun 28;: Authors: Wang X, Qu H, Dong Y, Wang G, Zhen Y, Yi P Abstract Melanoma treatment with the BRAF V600E inhibitor vemurafenib provides therapeutic benefits but the common emergence of drug resistance remains a challenge. To define molecular mechanisms of vemurafenib resistance, we generated A375-R, WM35-R cell lines resistant to vemurafenib and show that the phosphorylated (p)-STAT3 was upregulated in these cells in vitro and in vivo. In particular, ac...
Source: Cancer Biomarkers - Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: First Blood Test for Melanoma The first blood test to detect melanoma skin cancer in its early stages has been created by Australian...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Title: First Blood Test for MelanomaCategory: Health NewsCreated: 7/18/2018 12:00:00 AMLast Editorial Review: 7/18/2018 12:00:00 AM
Source: MedicineNet Cancer General - Category: Cancer & Oncology Source Type: news
(University of Sydney) A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely used sunscreen.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Biology | Cancer | Cancer & Oncology | Cytology | Melanoma | Skin Cancer